Related references
Note: Only part of the references are listed.Interaction of Exogenous Butyrylcholinesterase with β-Amyloid Plaques in 5XFAD/Butyrylcholinesterase-Knockout Mouse Brain
G. A. Reid et al.
CURRENT ALZHEIMER RESEARCH (2021)
Discovery, molecular dynamic simulation and biological evaluation of structurally diverse cholinesterase inhibitors with new scaffold through shape-based pharmacophore virtual screening
Hongyu Yang et al.
BIOORGANIC CHEMISTRY (2019)
Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors
Jun Mo et al.
BIOORGANIC CHEMISTRY (2019)
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
Qi Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
Qi Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease
Yao Chen et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode
Edgar Sawatzky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Development of an in-vivo active reversible butyrylcholinesterase inhibitor
Urban Kosak et al.
SCIENTIFIC REPORTS (2016)
Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice
Meaghan Morris et al.
NATURE NEUROSCIENCE (2015)
APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study
V. K. Ramanan et al.
MOLECULAR PSYCHIATRY (2014)
BUTYRYLCHOLINESTERASE AND THE CHOLINERGIC SYSTEM
G. A. Reid et al.
NEUROSCIENCE (2013)
Biochemical Differentiation of Cholinesterases from Normal and Alzheimer's Disease Cortex
Alexis Ciro et al.
CURRENT ALZHEIMER RESEARCH (2012)
Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice
Yoko Furukawa-Hibi et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Oxidative stress in Alzheimer disease
Alejandro Gella et al.
CELL ADHESION & MIGRATION (2009)
Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity
Joachim Hartmann et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Butyrylcholinesterase activity in the rat forebrain and upper brainstem: Postnatal development and adult distribution
Changiz Geula et al.
EXPERIMENTAL NEUROLOGY (2007)
A century of Alzheimer's disease
Michel Goedert et al.
SCIENCE (2006)
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
NH Greig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cholinesterase inhibitors: new roles and therapeutic alternatives
E Giacobini
PHARMACOLOGICAL RESEARCH (2004)
Treatment of Alzheimer's disease: current status and new perspectives
E Scarpini et al.
LANCET NEUROLOGY (2003)
Cholinergic function and Alzheimer's disease
E Giacobini
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
High throughput artificial membrane permeability assay for blood-brain barrier
L Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Neurobiology of butyrylcholinesterase
S Darvesh et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine
P Bar-On et al.
BIOCHEMISTRY (2002)
Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain
M Mesulam et al.
NEUROBIOLOGY OF DISEASE (2002)
Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine
MM Mesulam et al.
NEUROSCIENCE (2002)
Share Paper
